TTA-Q6

• Description:

  TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  405.8

• Molecular Formula:

  C20H15ClF3N3O

• Notes:

  Research use only, not for human use.

• Receptor:

  Calcium Channel

• CAS Number:

  910484-28-5